Abstract:Introduction: Prostate cancer (PC), which is a disease driven by the activity of the androgen receptor (AR), is the most commonly diagnosed malignancy and despite advances in diagnostic and treatment strategies, PC is the second most common cause of cancer mortality in men (Bray et al., 2018). Taxane-based chemotherapy is the only chemotherapy that prolongs survival in metastatic PC patients (Petrylak et al., 2004; Tannock et al., 2004). At the cellular level, taxanes bind to and stabilize microtubules (MTs) inhibiting all MT-dependent intracellular pathways. MTs are highly dynamic polymers that stochastically switch between phases of growth, shrinkage, and pause (Jordan and Wilson, 2004). Altered MT dynamics endow cancer cells with both survival and migratory advantages (Mitchison, 2012). Taxanes inhibit MT dynamics and alter the spatial organization of the MT network, thereby inhibiting intracellular trafficking of molecular cargo critical for tumor survival. In PC specifically, taxanes inhibit transcriptional activity downstream of MT stabilization (Thadani-Mulero et al., 2012) and AR nuclear accumulation (Darshan et al., 2011; Zhu et al., 2010). Methods: Different tubulin inhibitors, even from within the same structural class as the taxanes, affect distinct parameters of MT dynamics (Jordan and Wilson, 2004), yet the selection of taxane for chemotherapy is not based on the particular patterns of dynamic behavior of the MT cytoskeleton in individual patients. We envisage that systematic characterization using quantitative analysis of MT dynamics in PC patient cells expressing clinically relevant protein isoforms (Matov et al., 2024; Thoma et al., 2010), before and after treatment with each of the taxanes, will allow us to identify criteria for the selection of the most suitable drug combination at the onset of treatment. Results: We link MT dynamics in the presence of AR variants and sensitivity/resistance to taxanes and connect fundamental research with clinically relevant concepts to elucidate cellular mechanisms of clinical response to taxanes and, thus, advance the customization of therapy. Our computational live-cell analysis addresses questions in the context of the inherent differences in MT homeostasis as a function of AR content in PC cells, the specific parameters of MT dynamics each of the taxanes affects, and how can this information be used to match endogenous patterns of MT dynamics with drug-modulated MT behavior. Conclusion: We investigate whether the sensitivity to taxanes, evaluated by computational analysis of MTs, can be linked to gene expression correlated with AR and its variants, and whether the resistance to taxanes can be linked to the presence of a specific AR splice variant, and can we identify which of the taxanes will be most effective based on the endogenous patterns of MT dynamics.

Quantitative Microscopy in Medicine

Cryo-Imaging and Software Platform for Analysis of Molecular MR Imaging of Micrometastases

A Semi-Automatic Validation Tool for Whole Mouse Metastatic Tumor Molecular Imaging Using the Cryo-Imaging Cancer Imaging and Therapy Platform (CITP)

A Real-Time Suite of Biological Cell Image Analysis Software for Computers, Smartphones, and Smart Glasses, Suitable for Resource-Constrained Computing

PTOLEMI: Personalized Cancer Treatment through Machine Learning-Enabled Image Analysis of Microfluidic Assays

Automated Region-based Prostate Cancer Cell Nuclei Localization. Part of a Prognostic Modality Tool for Prostate Cancer Patients

Quantitative phase microscopy spatial signatures of cancer cells

Nuquantus: Machine learning software for the characterization and quantification of cell nuclei in complex immunofluorescent tissue images

Prostate Cancer Histopathology Using Label-Free Multispectral Deep-Uv Microscopy Quantifies Phenotypes of Tumor Aggressiveness and Enables Multiple Diagnostic Virtual Stains

Quantitative Image Analysis of Tissue Properties: A MATLAB Tool for Measuring Morphology and Co-localization in 2D Images

Software BreastAnalyser for the semi-automatic analysis of breast cancer immunohistochemical images

Prostate cancer histopathology with label-free multispectral deep UV microscopy quantifies phenotypes of tumor grade and aggressiveness

Innv-02. Brainmets: A Clinician-Friendly Software To Manually Segment Brain Metastases And Detect Primary Tumor Origin Using Deep Learning

Direct tool for quantitative analysis of cell/object dynamic behavior - metastasis and far beyond

Surface Reconstruction and Visualization of the Surgical Prostate Model

Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies

Quantitative Pathology in Tissue MR Spectroscopy Based Human Prostate Metabolomics

Computational Analysis of Treatment Resistant Cancer Cells

Towards semantic-driven high-content image analysis: an operational instantiation for mitosis detection in digital histopathology

Tumour immune characterisation of primary triple-negative breast cancer using automated image quantification of immunohistochemistry-stained immune cells

Scope2Screen: Focus+Context Techniques for Pathology Tumor Assessment in Multivariate Image Data